Anna E. L'Hommedieu

Represented an insurance company in conection with a grand jury subpoena related to a False Claims Act investigation.

Represented a Fortune 500 global healthcare and pharmaceutical company in SEC investigation relating to accounting practices. The SEC closed its investigation.

Advised a global public consumer goods company in parallel criminal and civil investigations brought by the DOJ and federal regulatory agencies involving alleged violations of the Food, Drug, and Cosmetic Act.

Represented a mortgage lender in a False Claims Act action brought by a qui tam plaintiff.

Conducted an internal investigation for a Fortune 500 global healthcare and pharmaceutical company into employee misconduct.

Represented the former CEO and Board Chairman of Russia’s largest privately held banking group in a criminal enforcement matter brought by DOJ’s KleptoCapture Task Force and the US Attorney’s Office for the Southern District of New York alleging violation of the International Emergency Economic Powers Act (IEEPA).

Represented a former Fortune 100 CEO in a grand jury investigation brought by the US Attorney’s Office for the Southern District of New York involving alleged fraud in connection with a multibillion-dollar infrastructure credit facility and sovereign guarantee.

Represented a senior executive in a Foreign Corrupt Practices Act investigation brought by the DOJ's FCPA Section.